Physician_Profile_ID,Category,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID,Total_Amount_of_Payment_USDollars,Date_of_Payment,Category,Record_ID
335947,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,69.00,11/14/2013,GNRL,31977660
335947,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,69.00,11/16/2014,GNRL,193765470
335947,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,44.06,02/04/2015,GNRL,260127170
335947,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,29.95,12/09/2015,GNRL,274997196
335947,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,28.51,02/07/2014,GNRL,148507802
335947,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,27.76,08/05/2015,GNRL,260027182
335947,GNRL,"Astellas Pharma US Inc",IL,100000000137,24.98,09/29/2015,GNRL,294940838
335947,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,24.70,01/16/2014,GNRL,149109464
335947,GNRL,"Novo Nordisk Inc",NJ,100000000144,24.57,12/22/2015,GNRL,267154046
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,24.31,11/15/2013,GNRL,100815852
335947,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,24.06,10/19/2015,GNRL,333519874
335947,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,23.98,04/29/2014,GNRL,150106482
335947,GNRL,"Sunovion Pharmaceuticals Inc.",MA,100000000254,22.87,09/29/2015,GNRL,321358209
335947,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,22.41,01/30/2015,GNRL,290756749
335947,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,22.29,09/10/2015,GNRL,260046654
335947,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,22.21,02/20/2014,GNRL,196625670
335947,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,22.20,06/05/2015,GNRL,260103608
335947,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,21.93,12/11/2013,GNRL,12250864
335947,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,21.72,01/22/2014,GNRL,193765407
335947,GNRL,"Novo Nordisk Inc",NJ,100000000144,21.70,09/13/2014,GNRL,162428236
335947,GNRL,"Lilly USA, LLC",IN,100000000066,21.35,06/18/2015,GNRL,267747730
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,21.26,08/01/2013,GNRL,100815848
335947,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,21.14,09/05/2014,GNRL,158711172
335947,GNRL,"Novo Nordisk Inc",NJ,100000000144,20.58,12/16/2015,GNRL,267164484
335947,GNRL,"VIVUS, Inc.",CA,100000005620,20.47,07/01/2015,GNRL,281450296
335947,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,20.40,03/17/2014,GNRL,196625666
335947,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,20.28,03/27/2014,GNRL,148727658
335947,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,20.17,11/27/2013,GNRL,100440634
335947,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,19.87,11/18/2015,GNRL,260114218
335947,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,19.61,04/09/2015,GNRL,260068274
335947,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,19.35,02/05/2015,GNRL,260095502
335947,GNRL,"Astellas Pharma US Inc",IL,100000000137,19.30,03/02/2015,GNRL,294803436
335947,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,19.08,03/31/2015,GNRL,290756746
335947,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,19.08,08/21/2015,GNRL,337310364
335947,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,18.96,05/15/2015,GNRL,290756738
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,18.82,10/07/2013,GNRL,100859702
335947,GNRL,"LILLY USA, LLC",IN,100000000066,18.79,10/16/2013,GNRL,4714989
335947,GNRL,"Novo Nordisk Inc",NJ,100000000144,18.76,10/10/2014,GNRL,162135176
335947,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,18.76,03/12/2014,GNRL,196625668
335947,GNRL,"Purdue Pharma L.P.",CT,100000005432,18.71,08/11/2015,GNRL,251022714
335947,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,18.56,02/18/2015,GNRL,318771957
335947,GNRL,"Novo Nordisk Inc",NJ,100000000144,18.55,06/10/2015,GNRL,266785906
335947,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,18.46,11/30/2015,GNRL,290756708
335947,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,18.41,12/17/2014,GNRL,193765482
335947,GNRL,"Purdue Pharma L.P.",CT,100000005432,18.39,03/04/2015,GNRL,251045164
335947,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,18.24,05/08/2014,GNRL,196625662
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,18.23,12/09/2013,GNRL,100815856
335947,GNRL,"Novo Nordisk Inc",NJ,100000000144,18.12,07/10/2014,GNRL,161788748
335947,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,18.05,06/19/2015,GNRL,290756730
335947,GNRL,"Lilly USA, LLC",IN,100000000066,17.96,03/03/2015,GNRL,267747728
335947,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,17.93,05/05/2015,GNRL,260062316
335947,GNRL,"Actavis Pharma Inc",NJ,100000010642,17.90,10/26/2015,GNRL,339652836
335947,GNRL,"Actavis Pharma Inc",NJ,100000010642,17.90,10/26/2015,GNRL,339652838
335947,GNRL,"Actavis Pharma Inc",NJ,100000010642,17.69,02/25/2015,GNRL,339644540
335947,GNRL,"AbbVie, Inc.",IL,100000000204,17.55,02/26/2015,GNRL,308933644
335947,GNRL,"Horizon Pharma plc","",100000131389,17.53,03/16/2015,GNRL,281929902
335947,GNRL,"Actavis Pharma Inc",NJ,100000010642,17.53,05/19/2015,GNRL,339637232
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,17.49,10/14/2014,GNRL,199573652
335947,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,17.37,12/10/2015,GNRL,260102702
335947,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,17.32,11/07/2013,GNRL,12166776
335947,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,17.31,04/25/2014,GNRL,150102818
335947,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,17.26,04/24/2015,GNRL,337127370
335947,GNRL,"AbbVie, Inc.",IL,100000000204,17.04,08/11/2013,GNRL,104615972
335947,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,17.02,11/11/2014,GNRL,149914208
335947,GNRL,"Novo Nordisk Inc",NJ,100000000144,16.89,05/27/2015,GNRL,266720674
335947,GNRL,"AbbVie, Inc.",IL,100000000204,16.82,04/02/2014,GNRL,189249172
335947,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,16.67,01/16/2014,GNRL,196625672
335947,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,16.64,03/27/2014,GNRL,193765424
335947,GNRL,"AbbVie, Inc.",IL,100000000204,16.62,11/24/2015,GNRL,316937400
335947,GNRL,"Novo Nordisk Inc",NJ,100000000144,16.56,02/21/2015,GNRL,267174650
335947,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,16.49,10/21/2014,GNRL,149736014
335947,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,16.49,03/23/2015,GNRL,260093670
335947,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,16.47,09/04/2014,GNRL,188772028
335947,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,16.41,03/30/2015,GNRL,260024322
335947,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,16.36,04/22/2015,GNRL,260093836
335947,GNRL,"Astellas Pharma US Inc",IL,100000000137,16.30,07/03/2015,GNRL,295275032
335947,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,16.27,10/13/2015,GNRL,336990276
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,16.11,06/10/2014,GNRL,199573650
335947,GNRL,"Novo Nordisk Inc",NJ,100000000144,15.99,01/26/2015,GNRL,266091596
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,15.94,02/26/2014,GNRL,199573646
335947,GNRL,"Pfizer Inc.",NY,100000000286,15.93,08/25/2015,GNRL,322631900
335947,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,15.92,03/20/2015,GNRL,260095932
335947,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,15.85,07/23/2015,GNRL,290140396
335947,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,15.83,04/23/2015,GNRL,333519868
335947,GNRL,"AbbVie, Inc.",IL,100000000204,15.81,11/21/2014,GNRL,189615026
335947,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,15.79,09/15/2014,GNRL,196625658
335947,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,15.79,06/29/2015,GNRL,337245160
335947,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,15.78,03/25/2014,GNRL,196625664
335947,GNRL,"Actavis Pharma Inc",NJ,100000010642,15.76,08/13/2015,GNRL,339545154
335947,GNRL,"Lilly USA, LLC",IN,100000000066,15.66,01/13/2015,GNRL,267747726
335947,GNRL,"Novo Nordisk Inc",NJ,100000000144,15.59,02/19/2014,GNRL,160698648
335947,GNRL,"Novo Nordisk Inc",NJ,100000000144,15.47,06/04/2014,GNRL,161445966
335947,GNRL,"Arbor Pharmaceuticals, Inc.",GA,100000005507,15.44,05/20/2015,GNRL,283393236
335947,GNRL,"Novo Nordisk Inc",NJ,100000000144,15.38,07/28/2014,GNRL,161915386
335947,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,15.36,07/09/2014,GNRL,201972474
335947,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,15.34,02/19/2015,GNRL,260072886
335947,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,15.26,07/21/2014,GNRL,187973634
335947,GNRL,"Actavis Pharma Inc",NJ,100000010642,15.06,11/03/2015,GNRL,339497956
335947,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,14.94,09/07/2013,GNRL,104407234
335947,GNRL,"Teva Pharmaceuticals USA, Inc.",PA,100000000141,14.94,11/04/2015,GNRL,293684196
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,14.78,06/25/2014,GNRL,199573642
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,14.73,05/29/2014,GNRL,199573640
335947,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,14.73,07/15/2014,GNRL,196625660
335947,GNRL,"Novo Nordisk Inc",NJ,100000000144,14.70,03/05/2015,GNRL,266351192
335947,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,14.69,10/23/2015,GNRL,290756716
335947,GNRL,"Purdue Pharma L.P.",CT,100000005432,14.54,01/06/2015,GNRL,251038482
335947,GNRL,"AbbVie, Inc.",IL,100000000204,14.37,11/20/2013,GNRL,104615970
335947,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,14.35,08/13/2013,GNRL,12167413
335947,GNRL,"Novo Nordisk Inc",NJ,100000000144,14.35,01/08/2014,GNRL,160732966
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,14.20,05/16/2014,GNRL,199573638
335947,GNRL,"Pfizer Inc.",NY,100000000286,14.18,01/14/2014,GNRL,207287230
335947,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,14.18,11/13/2015,GNRL,260098776
335947,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,14.17,09/18/2014,GNRL,149396826
335947,GNRL,"Lundbeck LLC",IL,100000000236,14.14,10/20/2015,GNRL,294124270
335947,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,14.10,08/27/2013,GNRL,103250816
335947,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,14.08,06/04/2015,GNRL,337178148
335947,GNRL,"Actavis Pharma Inc",NJ,100000010642,14.01,04/08/2015,GNRL,339437782
335947,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,14.00,09/08/2014,GNRL,150250462
335947,GNRL,"Pfizer Inc.",NY,100000000286,13.98,12/01/2015,GNRL,323924646
335947,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,13.89,12/15/2015,GNRL,260116822
335947,GNRL,"Purdue Pharma L.P.",CT,100000005432,13.86,10/29/2014,GNRL,158266104
335947,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,13.85,04/01/2014,GNRL,148255428
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,13.81,04/24/2014,GNRL,199573634
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,13.78,09/24/2013,GNRL,100787624
335947,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,13.67,02/13/2015,GNRL,336883668
335947,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,13.66,04/24/2014,GNRL,158634010
335947,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,13.65,02/24/2015,GNRL,260050428
335947,GNRL,"Pfizer Inc.",NY,100000000286,13.62,06/04/2014,GNRL,207282402
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,13.57,04/22/2014,GNRL,199573630
335947,GNRL,"Pfizer Inc.",NY,100000000286,13.57,04/08/2014,GNRL,206903838
335947,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,13.56,05/05/2015,GNRL,337120272
335947,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,13.53,12/23/2015,GNRL,290756704
335947,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,13.51,11/25/2014,GNRL,196625654
335947,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,13.50,08/24/2015,GNRL,260124644
335947,GNRL,"Pfizer Inc.",NY,100000000286,13.44,08/30/2014,GNRL,207346332
335947,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,13.41,09/26/2014,GNRL,150250944
335947,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,13.38,08/07/2013,GNRL,103250820
335947,GNRL,"Actavis Pharma Inc",NJ,100000010642,13.38,06/23/2015,GNRL,339401774
335947,GNRL,"Actavis Pharma Inc",NJ,100000010642,13.35,02/05/2015,GNRL,339400192
335947,GNRL,"Novo Nordisk Inc",NJ,100000000144,13.25,02/03/2015,GNRL,266196740
335947,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,13.23,06/16/2014,GNRL,149698819
335947,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,13.14,05/21/2014,GNRL,148442040
335947,GNRL,"Pfizer Inc.",NY,100000000286,13.14,02/25/2014,GNRL,206140434
335947,GNRL,"Arbor Pharmaceuticals, Inc.",GA,100000005507,13.06,08/25/2014,GNRL,217620172
335947,GNRL,"Arbor Pharmaceuticals, Inc.",GA,100000005507,13.06,07/29/2015,GNRL,283393238
335947,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,13.01,02/12/2015,GNRL,260109606
335947,GNRL,"Pfizer Inc.",NY,100000000286,12.98,11/21/2013,GNRL,205217610
335947,GNRL,"Pfizer Inc.",NY,100000000286,12.97,07/14/2015,GNRL,322791386
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,12.93,06/24/2014,GNRL,199573628
335947,GNRL,"Pfizer Inc.",NY,100000000286,12.85,05/28/2015,GNRL,323057022
335947,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,12.84,05/19/2014,GNRL,147712533
335947,GNRL,"Pfizer Inc.",NY,100000000286,12.83,09/10/2014,GNRL,206626186
335947,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,12.79,06/03/2015,GNRL,337476906
335947,GNRL,"Pfizer Inc.",NY,100000000286,12.74,09/13/2013,GNRL,205511216
335947,GNRL,"Pfizer Inc.",NY,100000000286,12.72,05/28/2014,GNRL,206588192
335947,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,12.71,02/04/2014,GNRL,152586912
335947,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,12.71,11/02/2015,GNRL,260116280
335947,GNRL,"Actavis Pharma Inc",NJ,100000010642,12.71,07/20/2015,GNRL,339364210
335947,GNRL,"Pfizer Inc.",NY,100000000286,12.62,10/22/2014,GNRL,206654358
335947,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,12.57,02/18/2014,GNRL,147712564
335947,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,12.54,01/05/2015,GNRL,330160517
335947,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,12.52,04/14/2014,GNRL,193765430
335947,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,12.50,05/29/2014,GNRL,149141620
335947,GNRL,"Pfizer Inc.",NY,100000000286,12.50,11/05/2014,GNRL,207069798
335947,GNRL,"Novo Nordisk Inc",NJ,100000000144,12.47,12/18/2013,GNRL,32248828
335947,GNRL,"LILLY USA, LLC",IN,100000000066,12.41,08/12/2014,GNRL,137913538
335947,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,12.37,04/28/2015,GNRL,260029736
335947,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,12.37,07/15/2015,GNRL,333519872
335947,GNRL,"Pfizer Inc.",NY,100000000286,12.35,11/05/2013,GNRL,205338696
335947,GNRL,"Pfizer Inc.",NY,100000000286,12.35,02/07/2015,GNRL,323462450
335947,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,12.31,08/20/2013,GNRL,24119937
335947,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,12.30,08/08/2013,GNRL,24119936
335947,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,12.29,06/16/2015,GNRL,260036868
335947,GNRL,"Iroko Pharmaceuticals, LLC",PA,100000011114,12.21,03/24/2014,GNRL,227835540
335947,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,12.18,11/14/2013,GNRL,100440632
335947,GNRL,"Novo Nordisk Inc",NJ,100000000144,12.18,11/04/2015,GNRL,267079208
335947,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,12.15,07/22/2015,GNRL,260033662
335947,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,12.14,08/23/2013,GNRL,12170058
335947,GNRL,"Pfizer Inc.",NY,100000000286,12.06,09/11/2013,GNRL,205517574
335947,GNRL,"Pfizer Inc.",NY,100000000286,12.06,06/02/2015,GNRL,323002424
335947,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,12.05,03/13/2014,GNRL,158594182
335947,GNRL,"Pfizer Inc.",NY,100000000286,11.97,04/21/2015,GNRL,323176830
335947,GNRL,"Pfizer Inc.",NY,100000000286,11.95,04/07/2015,GNRL,323867486
335947,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,11.93,09/12/2013,GNRL,104353826
335947,GNRL,"Pfizer Inc.",NY,100000000286,11.92,08/28/2014,GNRL,206418784
335947,GNRL,"Novo Nordisk Inc",NJ,100000000144,11.87,07/14/2015,GNRL,266875436
335947,GNRL,"Pfizer Inc.",NY,100000000286,11.81,06/11/2015,GNRL,323433736
335947,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,11.77,06/12/2014,GNRL,193765442
335947,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,11.76,07/13/2015,GNRL,290756726
335947,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,11.75,03/06/2015,GNRL,260120038
335947,GNRL,"Pfizer Inc.",NY,100000000286,11.74,03/14/2014,GNRL,206991168
335947,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,11.65,01/09/2015,GNRL,260065664
335947,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,11.61,01/21/2014,GNRL,147712588
335947,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,11.59,02/27/2014,GNRL,147712546
335947,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,11.54,08/14/2014,GNRL,149730460
335947,GNRL,"Pfizer Inc.",NY,100000000286,11.50,08/29/2013,GNRL,205357414
335947,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,11.49,05/12/2014,GNRL,147712529
335947,GNRL,"Novo Nordisk Inc",NJ,100000000144,11.49,02/12/2014,GNRL,160719892
335947,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,11.47,12/18/2014,GNRL,196625808
335947,GNRL,"Arbor Pharmaceuticals, Inc.",GA,100000005507,11.44,07/07/2014,GNRL,217620174
335947,GNRL,"Pfizer Inc.",NY,100000000286,11.40,01/06/2014,GNRL,207251550
335947,GNRL,"HOLOGIC INC",MA,100000010400,11.40,05/06/2015,GNRL,247073894
335947,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,11.38,12/15/2014,GNRL,149104370
335947,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,11.37,06/01/2015,GNRL,290756734
335947,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,11.30,10/18/2013,GNRL,14270740
335947,GNRL,"Arbor Pharmaceuticals, Inc.",GA,100000005507,11.28,12/09/2015,GNRL,283383744
335947,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,11.14,01/13/2014,GNRL,152586918
335947,GNRL,"Mallinckrodt LLC",MO,100000005429,11.12,04/23/2014,GNRL,210904492
335947,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,11.09,08/20/2014,GNRL,193765456
335947,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,11.08,02/17/2014,GNRL,148528050
335947,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,11.07,03/03/2014,GNRL,147712512
335947,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,11.04,04/01/2015,GNRL,290756740
335947,GNRL,"Amgen Inc.",CA,100000000203,10.99,09/20/2013,GNRL,8941823
335947,GNRL,"Lilly USA, LLC",IN,100000000066,10.99,09/02/2015,GNRL,267747732
335947,GNRL,"Amgen Inc.",CA,100000000203,10.97,03/11/2015,GNRL,297320300
335947,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,10.95,03/28/2014,GNRL,147712560
335947,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,10.91,12/10/2013,GNRL,12103499
335947,GNRL,"Ironwood Pharmaceuticals, Inc",MA,100000000245,10.91,04/30/2014,GNRL,191580660
335947,GNRL,"Pfizer Inc.",NY,100000000286,10.89,10/21/2014,GNRL,206692256
335947,GNRL,"Ironwood Pharmaceuticals, Inc",MA,100000000245,10.87,08/11/2014,GNRL,191580666
335947,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,10.87,12/17/2015,GNRL,319821578
335947,GNRL,"Teva Pharmaceuticals USA, Inc.",PA,100000000141,10.80,09/09/2013,GNRL,102153404
335947,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,10.80,03/06/2014,GNRL,152586914
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,10.75,05/16/2014,GNRL,199573626
335947,GNRL,"Pfizer Inc.",NY,100000000286,10.75,05/20/2014,GNRL,206193069
335947,GNRL,"Pfizer Inc.",NY,100000000286,10.70,12/04/2013,GNRL,205574534
335947,GNRL,"Pfizer Inc.",NY,100000000286,10.69,05/07/2015,GNRL,322483756
335947,GNRL,"Actavis Pharma Inc",NJ,100000010642,10.68,07/16/2015,GNRL,339192000
335947,GNRL,"Purdue Pharma L.P.",CT,100000005432,10.63,11/11/2015,GNRL,251144572
335947,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,10.60,02/06/2014,GNRL,187765412
335947,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,10.54,12/05/2013,GNRL,100440612
335947,GNRL,"Pfizer Inc.",NY,100000000286,10.53,10/07/2015,GNRL,323168650
335947,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,10.53,04/27/2015,GNRL,337108838
335947,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,10.52,03/12/2015,GNRL,337034114
335947,GNRL,"Actavis Pharma Inc",NJ,100000010642,10.51,10/05/2015,GNRL,339170778
335947,GNRL,"Pfizer Inc.",NY,100000000286,10.49,02/13/2014,GNRL,207115294
335947,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,10.49,12/16/2014,GNRL,188184870
335947,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,10.46,11/04/2013,GNRL,24119934
335947,GNRL,"Pfizer Inc.",NY,100000000286,10.39,11/06/2015,GNRL,323566058
335947,GNRL,"Actavis Pharma Inc",NJ,100000010642,10.25,06/08/2015,GNRL,339152488
335947,GNRL,"Pfizer Inc.",NY,100000000286,10.23,02/24/2015,GNRL,323969654
335947,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,10.22,02/28/2014,GNRL,150846751
335947,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,10.21,04/15/2014,GNRL,152586916
335947,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,10.17,09/16/2013,GNRL,24119935
335947,GNRL,"Pfizer Inc.",NY,100000000286,10.15,08/05/2015,GNRL,323212934
335947,GNRL,"Pfizer Inc.",NY,100000000286,10.14,10/09/2013,GNRL,205138490
335947,GNRL,"Eisai Inc.",NJ,100000000136,10.13,05/13/2014,GNRL,184566616
335947,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,10.13,01/27/2014,GNRL,147712524
335947,GNRL,"Pfizer Inc.",NY,100000000286,10.09,11/05/2015,GNRL,323597166
335947,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,10.00,09/24/2015,GNRL,336982548
335947,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,9.94,09/09/2015,GNRL,290756720
335947,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,9.93,02/10/2014,GNRL,193765496
335947,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,9.92,11/10/2014,GNRL,193765465
335947,GNRL,"Pfizer Inc.",NY,100000000286,9.91,10/02/2013,GNRL,205548578
335947,GNRL,"INSYS Therapeutics Inc",AZ,100000011066,9.81,05/08/2015,GNRL,285387985
335947,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,9.79,08/15/2013,GNRL,103250814
335947,GNRL,"INSYS Therapeutics Inc",AZ,100000011066,9.79,06/17/2015,GNRL,285388020
335947,GNRL,"Pfizer Inc.",NY,100000000286,9.76,07/30/2014,GNRL,206383568
335947,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,9.74,08/27/2015,GNRL,330822097
335947,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,9.73,02/11/2014,GNRL,201081344
335947,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,9.65,11/23/2015,GNRL,290756712
335947,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,9.56,08/12/2013,GNRL,100440626
335947,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,9.52,01/28/2015,GNRL,330154641
335947,GNRL,"Pfizer Inc.",NY,100000000286,9.43,03/10/2015,GNRL,323005470
335947,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,9.41,10/23/2014,GNRL,196625656
335947,GNRL,"Pfizer Inc.",NY,100000000286,9.30,07/01/2015,GNRL,323567431
335947,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,9.25,10/24/2014,GNRL,147712600
335947,GNRL,"Novo Nordisk Inc",NJ,100000000144,8.88,08/11/2015,GNRL,266937668
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,8.83,11/07/2014,GNRL,199573622
335947,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,8.78,10/01/2013,GNRL,100440624
335947,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,8.78,10/28/2014,GNRL,202339718
335947,GNRL,"Novo Nordisk Inc",NJ,100000000144,8.69,06/18/2015,GNRL,266801366
335947,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,8.69,03/25/2015,GNRL,330357231
335947,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,8.67,11/06/2013,GNRL,100440622
335947,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,8.64,09/24/2015,GNRL,330898037
335947,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,8.56,12/10/2014,GNRL,147712592
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,8.53,03/05/2014,GNRL,199573618
335947,GNRL,"LILLY USA, LLC",IN,100000000066,8.50,08/06/2013,GNRL,4725993
335947,GNRL,"Pfizer Inc.",NY,100000000286,8.48,08/19/2014,GNRL,206735260
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,8.37,09/17/2014,GNRL,199573614
335947,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,8.32,02/07/2014,GNRL,147712541
335947,GNRL,"Novo Nordisk Inc",NJ,100000000144,8.24,01/09/2015,GNRL,265957918
335947,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,8.14,04/21/2014,GNRL,201534522
335947,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,7.91,12/07/2015,GNRL,331119725
335947,GNRL,"Pfizer Inc.",NY,100000000286,7.89,12/03/2013,GNRL,205159438
335947,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,7.87,12/16/2013,GNRL,100440640
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,7.83,08/28/2013,GNRL,100787620
335947,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,7.76,06/18/2014,GNRL,201817812
335947,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,7.58,12/01/2014,GNRL,202528742
335947,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,7.56,03/04/2014,GNRL,201350210
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,7.53,10/30/2014,GNRL,199573612
335947,GNRL,"Pfizer Inc.",NY,100000000286,7.50,11/20/2014,GNRL,207231752
335947,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,7.44,10/21/2013,GNRL,100440638
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,7.33,11/27/2013,GNRL,100859704
335947,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,7.30,03/18/2015,GNRL,330294385
335947,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,7.25,11/19/2014,GNRL,147712579
335947,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,7.18,06/25/2015,GNRL,330640131
335947,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,7.11,10/21/2015,GNRL,330988477
335947,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,7.03,08/19/2015,GNRL,290756722
335947,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,6.72,12/08/2015,GNRL,331126241
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,6.68,11/24/2014,GNRL,199573610
335947,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,6.68,10/28/2015,GNRL,331016933
335947,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,6.57,09/11/2015,GNRL,330856589
335947,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,6.54,08/22/2014,GNRL,193765492
335947,GNRL,"Novo Nordisk Inc",NJ,100000000144,6.50,08/29/2014,GNRL,162330718
335947,GNRL,"Actavis Pharma Inc",NJ,100000010642,6.49,02/20/2015,GNRL,339038506
335947,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,6.48,05/29/2015,GNRL,330545035
335947,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,6.35,01/29/2015,GNRL,336849902
335947,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,6.31,03/11/2014,GNRL,201354650
335947,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,6.16,06/11/2014,GNRL,201707336
335947,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,6.15,05/28/2015,GNRL,330543535
335947,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,6.06,10/15/2015,GNRL,337376638
335947,GNRL,"Pfizer Inc.",NY,100000000286,5.95,04/07/2015,GNRL,323590534
335947,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,5.92,08/06/2015,GNRL,330841851
335947,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,5.87,02/17/2015,GNRL,330198173
335947,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,5.87,11/16/2015,GNRL,337408492
335947,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,5.82,05/05/2014,GNRL,201642064
335947,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,5.74,08/18/2014,GNRL,201950370
335947,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,5.74,08/17/2015,GNRL,330762141
335947,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,5.55,08/26/2013,GNRL,100440620
335947,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,5.54,04/16/2014,GNRL,201502896
335947,GNRL,"Actavis Pharma Inc",NJ,100000010642,5.47,06/11/2015,GNRL,339014020
335947,GNRL,"Actavis Pharma Inc",NJ,100000010642,5.43,11/23/2015,GNRL,339013116
335947,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,5.42,11/13/2013,GNRL,103250818
335947,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,5.39,03/07/2014,GNRL,147712552
335947,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,5.29,05/08/2014,GNRL,147712548
335947,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,5.26,03/20/2014,GNRL,193765504
335947,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,5.18,01/07/2015,GNRL,330120377
335947,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,5.12,09/24/2014,GNRL,202166696
335947,GNRL,"Novo Nordisk Inc",NJ,100000000144,4.92,09/25/2014,GNRL,162062354
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,4.89,12/03/2013,GNRL,100787634
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,4.77,04/30/2014,GNRL,199573608
335947,GNRL,"Actavis Pharma Inc",NJ,100000010642,4.73,05/15/2015,GNRL,338994886
335947,GNRL,"Actavis Pharma Inc",NJ,100000010642,4.64,04/08/2015,GNRL,338992680
335947,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,4.57,07/22/2014,GNRL,201897590
335947,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,4.44,09/29/2014,GNRL,202119369
335947,GNRL,"Actavis Pharma Inc",NJ,100000010642,4.40,05/05/2015,GNRL,338986636
335947,GNRL,"Novo Nordisk Inc",NJ,100000000144,4.39,08/29/2014,GNRL,162330714
335947,GNRL,"Pfizer Inc.",NY,100000000286,4.21,08/20/2015,GNRL,322735340
335947,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,4.10,03/10/2014,GNRL,201256882
335947,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,4.01,09/09/2013,GNRL,103250810
335947,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,4.00,08/22/2013,GNRL,100440636
335947,GNRL,"Novo Nordisk Inc",NJ,100000000144,3.90,08/19/2014,GNRL,161857366
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,3.67,09/17/2014,GNRL,199573604
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,3.54,12/20/2013,GNRL,100787638
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,3.54,02/04/2014,GNRL,199573602
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,3.21,01/23/2014,GNRL,199573598
335947,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,2.90,02/11/2015,GNRL,330195155
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,2.88,11/05/2013,GNRL,100787630
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,2.88,05/13/2014,GNRL,199573594
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,2.88,03/25/2014,GNRL,199573586
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,2.88,04/15/2014,GNRL,199573590
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,2.88,02/26/2014,GNRL,199573580
335947,GNRL,"Pfizer Inc.",NY,100000000286,2.85,09/13/2013,GNRL,205748628
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,2.75,09/12/2014,GNRL,199573577
335947,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,2.71,08/23/2013,GNRL,100440618
335947,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,2.56,09/09/2013,GNRL,103250812
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,2.50,08/25/2014,GNRL,199573574
335947,GNRL,"Actavis Pharma Inc",NJ,100000010642,2.40,08/13/2015,GNRL,338909566
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,2.36,10/03/2014,GNRL,199573570
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,2.36,12/02/2014,GNRL,199573566
335947,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,2.25,11/22/2013,GNRL,100440630
335947,GNRL,"Novo Nordisk Inc",NJ,100000000144,2.12,11/04/2015,GNRL,267079372
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,2.06,08/20/2013,GNRL,100787618
335947,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,2.02,06/10/2014,GNRL,147712520
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,1.94,10/07/2014,GNRL,199573562
335947,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,1.86,06/11/2014,GNRL,193765450
335947,GNRL,"Actavis Pharma Inc",NJ,100000010642,1.83,08/04/2015,GNRL,338890602
335947,GNRL,"Pfizer Inc.",NY,100000000286,1.78,04/07/2015,GNRL,323888424
335947,GNRL,"Actavis Pharma Inc",NJ,100000010642,1.75,07/23/2015,GNRL,338888562
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,1.71,10/15/2013,GNRL,100787628
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,1.71,11/11/2014,GNRL,199573552
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,1.71,12/09/2014,GNRL,199573548
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,1.71,11/18/2014,GNRL,199573556
335947,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,1.70,12/13/2013,GNRL,100440628
335947,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,1.69,11/11/2013,GNRL,100440616
335947,GNRL,"Novo Nordisk Inc",NJ,100000000144,1.61,09/12/2014,GNRL,162072646
335947,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,1.60,03/27/2014,GNRL,149964950
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,1.58,03/31/2014,GNRL,199573544
335947,GNRL,"Actavis Pharma Inc",NJ,100000010642,1.54,07/20/2015,GNRL,338884214
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,1.53,11/24/2014,GNRL,199573542
335947,GNRL,"Novo Nordisk Inc",NJ,100000000144,1.53,02/20/2015,GNRL,266245727
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,1.50,08/28/2013,GNRL,100787622
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,1.50,08/19/2014,GNRL,199573540
335947,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,1.48,11/19/2015,GNRL,290756696
335947,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,1.48,07/31/2015,GNRL,290756700
335947,GNRL,"INSYS Therapeutics Inc",AZ,100000011066,1.45,05/08/2015,GNRL,285388006
335947,GNRL,"Novo Nordisk Inc",NJ,100000000144,1.44,05/26/2015,GNRL,266720678
335947,GNRL,"Actavis Pharma Inc",NJ,100000010642,1.41,10/19/2015,GNRL,338881462
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,1.40,09/02/2014,GNRL,199573536
335947,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,1.38,09/30/2013,GNRL,100440614
335947,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,1.38,01/13/2014,GNRL,147712538
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,1.32,12/17/2013,GNRL,100787636
335947,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,1.29,01/02/2014,GNRL,147712570
335947,GNRL,"Pfizer Inc.",NY,100000000286,1.24,05/19/2014,GNRL,207282026
335947,GNRL,"Actavis Pharma Inc",NJ,100000010642,1.23,10/05/2015,GNRL,338878230
335947,GNRL,"Novo Nordisk Inc",NJ,100000000144,1.22,06/03/2014,GNRL,161444420
335947,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,1.21,11/19/2014,GNRL,147712596
335947,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,1.20,01/15/2014,GNRL,147712584
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,1.18,03/05/2014,GNRL,199573534
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,1.10,08/01/2013,GNRL,100815846
335947,GNRL,"Novo Nordisk Inc",NJ,100000000144,1.06,10/09/2014,GNRL,162135174
335947,GNRL,"Actavis Pharma Inc",NJ,100000010642,1.06,06/23/2015,GNRL,338875206
335947,GNRL,"Pfizer Inc.",NY,100000000286,1.02,03/10/2015,GNRL,323236400
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,1.00,10/28/2014,GNRL,199573530
335947,GNRL,"Pfizer Inc.",NY,100000000286,1.00,05/27/2015,GNRL,322956810
335947,GNRL,"Pfizer Inc.",NY,100000000286,0.99,10/06/2015,GNRL,323469262
335947,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,0.98,03/10/2014,GNRL,147712556
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,0.98,04/22/2014,GNRL,199573528
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,0.97,06/24/2014,GNRL,199573526
335947,GNRL,"Pfizer Inc.",NY,100000000286,0.93,04/06/2015,GNRL,322616036
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,0.89,09/17/2014,GNRL,199573522
335947,GNRL,"Pfizer Inc.",NY,100000000286,0.88,11/05/2015,GNRL,323678073
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,0.87,08/13/2013,GNRL,100787616
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,0.87,12/03/2013,GNRL,100787632
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,0.87,01/21/2014,GNRL,199573514
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,0.87,02/18/2014,GNRL,199573518
335947,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,0.85,12/13/2013,GNRL,100440610
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,0.85,09/24/2013,GNRL,100787626
335947,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,0.85,08/11/2014,GNRL,147712574
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,0.82,12/09/2013,GNRL,100815854
335947,GNRL,"Pfizer Inc.",NY,100000000286,0.79,10/20/2014,GNRL,207355058
335947,GNRL,"Pfizer Inc.",NY,100000000286,0.78,01/14/2014,GNRL,205674225
335947,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,0.74,03/17/2014,GNRL,147712516
335947,GNRL,"Pfizer Inc.",NY,100000000286,0.71,02/23/2015,GNRL,323864834
335947,GNRL,"Pfizer Inc.",NY,100000000286,0.68,07/30/2014,GNRL,206608790
335947,GNRL,"Pfizer Inc.",NY,100000000286,0.68,02/25/2014,GNRL,206391714
335947,GNRL,"Pfizer Inc.",NY,100000000286,0.67,04/21/2015,GNRL,322462230
335947,GNRL,"Pfizer Inc.",NY,100000000286,0.65,11/05/2013,GNRL,205279453
335947,GNRL,"Pfizer Inc.",NY,100000000286,0.65,07/14/2015,GNRL,322721746
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,0.62,11/07/2014,GNRL,199573510
335947,GNRL,"Pfizer Inc.",NY,100000000286,0.60,09/10/2014,GNRL,206845066
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,0.59,11/15/2013,GNRL,100815850
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,0.59,11/24/2014,GNRL,199573506
335947,GNRL,"Pfizer Inc.",NY,100000000286,0.59,06/02/2015,GNRL,322448264
335947,GNRL,"Pfizer Inc.",NY,100000000286,0.59,08/25/2015,GNRL,323276852
335947,GNRL,"Pfizer Inc.",NY,100000000286,0.58,08/29/2013,GNRL,205468096
335947,GNRL,"Pfizer Inc.",NY,100000000286,0.55,10/09/2013,GNRL,205603184
335947,GNRL,"Pfizer Inc.",NY,100000000286,0.55,06/04/2014,GNRL,206283730
335947,GNRL,"Pfizer Inc.",NY,100000000286,0.55,11/20/2014,GNRL,206908328
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,0.54,02/26/2014,GNRL,199573498
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,0.54,05/27/2014,GNRL,199573502
335947,GNRL,"Pfizer Inc.",NY,100000000286,0.52,02/13/2014,GNRL,207217944
335947,GNRL,"Pfizer Inc.",NY,100000000286,0.48,06/11/2015,GNRL,323945456
335947,GNRL,"Pfizer Inc.",NY,100000000286,0.47,12/04/2013,GNRL,205604829
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,0.46,03/05/2014,GNRL,199573494
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,0.45,06/10/2014,GNRL,199573490
335947,GNRL,"Pfizer Inc.",NY,100000000286,0.39,11/21/2013,GNRL,205198720
335947,GNRL,"Pfizer Inc.",NY,100000000286,0.39,04/08/2014,GNRL,205623847
335947,GNRL,"Pfizer Inc.",NY,100000000286,0.39,08/28/2014,GNRL,206061859
335947,GNRL,"Pfizer Inc.",NY,100000000286,0.38,12/01/2015,GNRL,323741720
335947,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,0.36,10/30/2014,GNRL,199573486
335947,GNRL,"Pfizer Inc.",NY,100000000286,0.35,11/05/2014,GNRL,206090582
335947,GNRL,"Pfizer Inc.",NY,100000000286,0.26,11/05/2014,GNRL,205792064
